Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHSE: 600557)
Health Care · Pharmaceuticals · CN
CN¥12.06
-6.80% today · -36.2% 1Y
Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHSE: 600557) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.02B and employs 5,379 people.
Over the last twelve months the share price has lost 36.2%, trading between 10.69 and 19.25.
Tweenvest scores Jiangsu Kanion Pharmaceutical Co.,Ltd. across four factors: quality 74/100, value 55/100, growth 8/100. Its strongest factor is quality.
600557 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.02B
- Revenue (TTM)
- $470.70M
- P/E
- 22.74
- EPS
- 0.53
- Dividend yield
- —
- Beta (5Y)
- 0.42
- 52-week high
- CN¥19.25
- 52-week low
- CN¥10.69
- Avg volume (3M)
- —
- Shares outstanding
- 566.16M
- Employees
- 5,379
- Next earnings
- —
About Jiangsu Kanion Pharmaceutical Co.,Ltd.
Jiangsu Kanion Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise focused on the research, development, production, and distribution of traditional Chinese medicines. The company's diverse product range targets several therapeutic areas, such as women's health, bone and joint conditions, antiviral treatments, and cardiovascular and cerebrovascular ailments. Founded in 1975, its primary operations are based in Lianyungang, China.
- ISIN
- CNE000001CL7
- Founded
- 1975
- Listed since
- Sep 18, 2002
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.